COASTLANDS CAPITAL LP purchased 0.8% of their position (3.23K shares) of ADIAL PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $8.7K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 7/16/2026ACC: 0001104659-26-084300
10% Owner
Since Jun 2026
+3.23K
Net shares
Net buyer
$8.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
3.23K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+2K
Price / share
$2.65
Trade value
$5.30K
% of position
0.5%
7/14/2026
385.07K→387.07K
Common Stock
Indirect
Shares
+1.23K
Price / share
$2.75
Trade value
$3.39K
% of position
0.3%
7/16/2026
387.07K→388.31K
Total
Net shares
+3.23K
Net value
$8.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/14/2026 | P · Purchase | +2K | $2.65 | $5.30K | 0.5% | 385.07K | 387.07K |
| Common Stock Indirect | 7/16/2026 | P · Purchase | +1.23K | $2.75 | $3.39K | 0.3% | 387.07K | 388.31K |
| Total | +3.23K | $8.69K | ||||||
Derivative Transactions0
No derivative transactions reported